Does the fine‐needle aspiration diagnosis of “Hürthle‐cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy?

The thyroid fine‐needle aspiration (FNA) diagnosis of Hürthle‐cell neoplasm (HCN)/follicular neoplasm with oncocytic features (FNOF) does not differentiate between Hürthle‐cell adenoma and carcinoma. A majority of cases diagnosed as HCN undergo surgical excision for definite characterization. The aim of this study was to determine the risk of malignancy in cases diagnosed as HCN and identify clinical features that may help in predicting malignancy in patients with FNA diagnosis of HCN.

[1]  D. Myssiorek,et al.  Hurthle Cell Neoplasms of the Thyroid , 2002, The Laryngoscope.

[2]  Z. Baloch,et al.  Intraoperative assessment of thyroid and parathyroid lesions. , 2002, Seminars in diagnostic pathology.

[3]  A. Renshaw.  How closely do thyroid fine‐needle aspirates need to be screened? , 2002, Diagnostic cytopathology.

[4]  A. Renshaw.  Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine‐needle aspiration of the thyroid , 2002, Cancer.

[5]  B. Delahunt,et al.  High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  Z. Baloch,et al.  Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology , 2002, Diagnostic cytopathology.

[7]  K. Khurana,et al.  Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hürthle cell lesions by fine-needle aspiration. , 2001, Archives of pathology & laboratory medicine.

[8]  M. Zou,et al.  Cyclin D1 in thyroid carcinomas. , 2001, Thyroid : official journal of the American Thyroid Association.

[9]  R. Spiro,et al.  Hürthle cell carcinoma: a critical histopathologic appraisal. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  K. Azarow,et al.  Does telomerase activity add to the value of fine needle aspirations in evaluating thyroid nodules? , 2001, American journal of surgery.

[11]  W. Westra,et al.  Randomized Prospective Evaluation of Frozen-Section Analysis for Follicular Neoplasms of the Thyroid , 2001, Annals of surgery.

[12]  G. Fontanini,et al.  Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. , 2000, Thyroid : official journal of the American Thyroid Association.

[13]  Z. Baloch,et al.  Warthin-like papillary carcinoma of the thyroid. , 2000, Archives of pathology & laboratory medicine.

[14]  J. Shah,et al.  Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.

[15]  A. Khiyami,et al.  Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? , 1999, Surgery.

[16]  M. Bibbo,et al.  Differential Diagnosis of Oncocytic Lesions of the Breast and Thyroid Utilizing a Semiquantitative Approach , 1999, Acta Cytologica.

[17]  D. Zelterman,et al.  Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. , 1999, The American journal of surgical pathology.

[18]  G. Jayaram,et al.  Fine needle aspiration cytology of the thyroid--a review of experience in 1853 cases. , 1999, The Malaysian journal of pathology.

[19]  Z. Baloch,et al.  Oncocytic Lesions of the Neuroendocrine System , 1999, Seminars in diagnostic pathology.

[20]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[21]  M. Silverman,et al.  Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. , 1998, Surgery.

[22]  C. McHenry,et al.  Management of follicular and Hürthle cell neoplasms of the thyroid gland. , 1998, Surgical oncology clinics of North America.

[23]  S. Savin,et al.  Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. , 1998, Anticancer research.

[24]  S. Piantadosi,et al.  Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. , 1998, The Journal of clinical endocrinology and metabolism.

[25]  R. Tuttle,et al.  Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. , 1998, Thyroid : official journal of the American Thyroid Association.

[26]  A. Kovatich,et al.  Immunocytochemical evaluation of HBME‐1, CA 19‐9, and CD‐15 (Leu‐M1) in fine‐needle aspirates of thyroid nodules , 1998, Diagnostic cytopathology.

[27]  D. Clark,et al.  Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasms. , 1997, Thyroid : official journal of the American Thyroid Association.

[28]  N. Eberhardt,et al.  Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.

[29]  H. Gharib,et al.  Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is “Suspicious for Follicular Neoplasm” , 1997 .

[30]  A. Venditti,et al.  [Clinical significance of Hürthle cell in the cytology of thyroid disease]. , 1997, Recenti progressi in medicina.

[31]  M. Miettinen,et al.  Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours , 1996, Virchows Archiv.

[32]  G. Daniels,et al.  Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. , 1996, Acta cytologica.

[33]  S. Al-Sedairy,et al.  The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis , 1995, Cancer.

[34]  D. Tyler,et al.  Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. , 1994, Surgery.

[35]  R. Robins,et al.  Clinical parameters predictive of malignancy of thyroid follicular neoplasms. , 1991, American journal of surgery.

[36]  J. Rodier,et al.  [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases]. , 1989, Journal de chirurgie.

[37]  I. Hay,et al.  Benign Hürthle cell tumors of the thyroid: A diagnosis to be trusted? , 1988, World Journal of Surgery.

[38]  M. Bronner,et al.  Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. , 1988, American journal of clinical pathology.

[39]  Joensuu,et al.  DNA aneuploidy in follicular adenomas of the thyroid gland. , 1986, The American journal of pathology.

[40]  E. Lerma,et al.  Hürthle cell and mitochondrion‐rich cell tumors. A clinicopathologic study , 1986, Cancer.

[41]  R. Lloyd,et al.  Follicular carcinoma of the thyroid gland: trends and treatment. , 1984, Surgery.

[42]  O. Clark,et al.  Hürthle cell neoplasms. Malignant potential. , 1984, Archives of surgery.

[43]  S. Gundry,et al.  Total thyroidectomy for Hürthle cell neoplasm of the thyroid. , 1983, Archives of surgery.

[44]  S. Kini,et al.  Cytopathology of Hürthle cell lesions of the thyroid gland by fine needle aspiration. , 1981, Acta cytologica.

[45]  Dunn El,et al.  Hürthle cell lesions of the thyroid gland. , 1974, Surgery, gynecology & obstetrics.

[46]  J. Hazard,et al.  Atypical adenoma of the thyroid. , 1954, A.M.A. archives of pathology.

[47]  Gilmore Hr,et al.  Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.

[48]  D. Clark,et al.  Beyond the suspicious thyroid fine needle aspirate. A review. , 2003, Acta cytologica.

[49]  H. Gharib,et al.  Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". , 1997, Mayo Clinic proceedings.

[50]  A. Bankfalvi,et al.  Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma: A molecular-pathological and immunohistochemical study on paraffin-embedded tissue , 1996, Endocrine pathology.

[51]  V. Livolsi.  The pathology of autoimmune thyroid disease: a review. , 1994, Thyroid : official journal of the American Thyroid Association.

[52]  B. Cochand‐Priollet.  [Follicular Hürthle cell tumors of the thyroid gland]. , 1992, Annales de pathologie.

[53]  H. Rieger,et al.  [The importance of atypical adenoma of the thyroid gland]. , 1988, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie.

[54]  S. Kini,et al.  Cytopathology of thyroid nodules. , 1982, Henry Ford Hospital medical journal.

[55]  M. Mosonyi.  [Hürthle cell tumor of the thyroid gland]. , 1951, Kiserletes orvostudomany.